Company overview

PT Boehringer Ingelheim Indonesia

Name

PT Boehringer Ingelheim Indonesia

Entity type

PT (Limited Liability Company)

Province

DKI Jakarta

Regency

Kota Adm. Jakarta Selatan

District

Kebayoran Baru

Village

Senayan

Address

Sequis Tower Level 22 Unit 5, Jl. Jend. Sudirman Kav. 71

Postal code

12190

Country

Indonesia

Primary goods traded

  • 65.4% — Medicaments (300490)
  • 15.6% — Blood, human or animal, antisera, other blood fractions and immunological products (300215)
  • 6.9% — Alkaloids (293979)
  • 6.5% — Amine-function compounds (292159)
  • 5.6% — Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters (292219)
BPOM Products
Register NumberBrandForm
11 October 2018
PHARMATON FORMULA
SL091300431-Kapsul Lunak
0 of 1 row(s) selected.
Main Trading Partners
PartnerTypeTotal ValuePercentage
Dksh Malaysia Sdn. Bhd.buyer$1,830,8380.50%
Loading chart...
Loading chart...
Trade Data
Data SourceHS CodeDescriptionBuyerBuyer CountrySellerSeller Country
18 September 2024ID30049059Bisolvon Tablets101177
Sanofi Vietnam Shareholding Company
VNPT Boehringer Ingelheim IndonesiaID$76,800.47
18 September 2024ID30049059Bisolvon Tablets101177
Sanofi Vietnam Shareholding Company
VNPT Boehringer Ingelheim IndonesiaID$112,767.76
18 September 2024ID30049059Bisolvon Tablets101177
Sanofi Vietnam Shareholding Company
VNPT Boehringer Ingelheim IndonesiaID$111,479.11
18 September 2024ID30049059Bisolvon Tablets101177
Sanofi Vietnam Shareholding Company
VNPT Boehringer Ingelheim IndonesiaID$112,993.83
11 September 2024ID30049099Dulcolax,adsup/ 50/10Mg341550
Opella Healthcare Korea Limited
KRPT Boehringer Ingelheim IndonesiaID$196,476.14
0 of 5 row(s) selected.